The top 20 pathways were determined (Fig. 1d), mainly including pathways in non-alcoholic fatty liver disease (NAFLD), PI3K-AKT signaling pathway, AD, and other dysregulation of predominantly inflammatory signaling pathways. Here, AKT1 is linked to metabolic dysfunction-associated steatotic liver disease.